Medicines of botanical origin for the treatment of addictions

NFL Biosciences develops botanical medicines for the treatment of addictions, with the goal of eventually partnering them with pharmaceutical companies
bt_bb_section_bottom_section_coverage_image

Our expertise

Focus on the 3 most common addictive substances, which are frequently present at the same time

Revolutionizing withdrawal treatments

NFL-101: An innovative drug candidate for smoking cessation derived from a nicotine-free tobacco leaf protein extract

NFL 301: A drug candidate to combat excessive alcohol consumption from a traditional Chinese medicine plant

NFL BIOSCIENCES KEY FIGURES

2021
Initial Public Offering
8 m€
raised on Euronext Growth
3
clinical studies on NFL-101

An outsourced scientific research company with low operating costs

PRECLINICAL AND CLINICAL STUDIES
HIGH ENVIRONMENTAL IMPACT APPROACH
SEVERAL SCIENTIFIC AWARDS
GLOBAL SCIENTIFIC EXPERTISE IN BOTANICAL MEDICINES
4 PATENT FAMILIES
MANUFACTURING IN FRANCE AND RESPECT FOR BPF